Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-PBA in Alpha 1-Antitrypsin Deficiency
NCT00067756Phase 2Completed
- Sponsor
- University of Florida
- Start
- Nov 2001
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium phenylbutyrate in alpha-1 antitrypsin deficiency (AATD), sponsored by University of Florida. Started Nov 2001; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
alpha-1 antitrypsin deficiency (AATD)
Beyond the preview
Go deeper on NCT00067756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067756.